x 

0 Activities
0 Activities
    • No Saved Activities
Page 2 of 2
Results 76 - 95 of 95
No image set
Gene Therapy for Treatment of Hemophilia: Other Strategies and Targets
9915-conf_covg_icon_263x149
Conference Coverage from ISTH 2019 in Melbourne
9915-mod3-icon
A History of Hemophilia Treatment: Non-replacement Therapy to Gene Therapy
No image set
Gene Therapy for Treatment of Hemophilia: Common Concerns in Gene Therapy
9915-mod2-icon
A History of Hemophilia Treatment: Factor Replacement to Gene Therapy
9915-mod1-icon
Getting to Know Gene Therapy: Terminology and Concepts
hopa-icon8
Biosimilars: Applying the Science to Hematology/Oncology Practice
biosims-archmed icon
Top Questions about Biosimilars in Hematology/Oncology
IL-fund-case4
Interchangeability and Pharmacy-Level Substitution
IL-fund-case3
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
IL-fund-case2
What is the Difference Between a Biosimilar and a Generic?
IL-fund-case1
What is a Biologic?
biosims-full
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
biosims-full3
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
biosims-green3
Pharmacovigilance and Biosimilars: Any Special Considerations?
biosims-full5
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
biosims-green8
Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?
biosims-full7
Biosimilars: As Safe and Effective as the Reference Product?
biosims-green
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
biosims-full8
Biosimilars in Clinical Practice: Interchangeability and Extrapolation
Page 2 of 2

Search